OCAFP - Geographic variation

Highlights

Given the disparity in ovarian cancer survival highlighted in the first report, this second output looks to see whether some of this variation may be attributable to differences in clinical practice across regions of England.

Results indicate that the probability of accessing surgery and chemotherapy varies across England, even after accounting for differences in patient and tumour characteristics.

These findings indicate an opportunity for identifying examples of best practice that could be disseminated to Cancer Alliances where treatment probabilities are lower, leading to improvements in therapy and better outcomes for women with ovarian cancer.